Full-atomistic molecular dynamics analysis of p53 active tetramer

被引:2
|
作者
Zhou Han [1 ]
Geng Yi-Zhao [2 ]
Yan Shi-Wei [1 ,3 ]
机构
[1] Beijing Normal Univ, Dept Phys, Beijing 100875, Peoples R China
[2] Hebei Univ Technol, Fac Sci, Tianjin 300131, Peoples R China
[3] Beijing Normal Univ, Fac Arts & Sci, Beijing 519085, Zhuhai, Peoples R China
基金
中国国家自然科学基金;
关键词
p53 core tetramer; p53 core domain; protein-protein interaction; molecular dynamics simulation; DNA-BINDING DOMAIN; CRYSTAL-STRUCTURE; MUTANT P53; STRUCTURAL BASIS; DIMERIZATION; RECOGNITION; COMPLEX; RESCUE; TP53; SITE;
D O I
10.7498/aps.73.20231515
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
p53 is a tumor suppressor protein that plays a crucial role in inhibiting cancer development and maintaining the genetic integrity. Within the cell nucleus, four p53 molecules constitute a stable tetrameric active structure through highly cooperative interactions, bind to DNA via its DNA-binding domain, and transcriptionally activate or inhibit their target genes. However, in most human tumor cells, there are numerous p53 mutations. The majority of these mutations are formed in the p53 DNA-binding domain, importantly, the p53 DNA-binding domain is critical for p53 to form the tetrameric active structures and to regulate the transcription of its downstream target genes. In this work, the all-atom molecular dynamics simulation is conducted to investigate the mechanism of interaction within the wild-type p53 tetramers. This study indicates that the symmetric dimers on either side of the DNA are stable ones, keeping stable structures before and after DNA binding. The binding of two monomers on the same side of the DNA depends on protein-protein interaction provided by two contact surfaces. DNA scaffold stabilizes the tetrameric active structure. Such interactions crucially contribute to the tetramer formation. This study clarifies the internal interactions and key residues within the p53 tetramer in dynamic process, as well as the critical sites at various interaction interfaces. The findings of this study may provide a significant foundation for us to further understand the p53's anticancer mechanisms, to explore the effective cancer treatment strategies, and in near future, to develop the effective anti-cancer drugs.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers
    Abraham, Mark James
    Murtola, Teemu
    Schulz, Roland
    Páll, Szilárd
    Smith, Jeremy C.
    Hess, Berk
    Lindah, Erik
    [J]. SoftwareX, 2015, 1-2 : 19 - 25
  • [2] Definition of the hydrogen bond (IUPAC Recommendations 2011)
    Arunan, Elangannan
    Desiraju, Gautam R.
    Klein, Roger A.
    Sadlej, Joanna
    Scheiner, Steve
    Alkorta, Ibon
    Clary, David C.
    Crabtree, Robert H.
    Dannenberg, Joseph J.
    Hobza, Pavel
    Kjaergaard, Henrik G.
    Legon, Anthony C.
    Mennucci, Benedetta
    Nesbitt, David J.
    [J]. PURE AND APPLIED CHEMISTRY, 2011, 83 (08) : 1637 - 1641
  • [3] 4 P53 DNA-BINDING DOMAIN PEPTIDES BIND NATURAL P53-RESPONSE ELEMENTS AND BEND THE DNA
    BALAGURUMOORTHY, P
    SAKAMOTO, H
    LEWIS, MS
    ZAMBRANO, N
    CLORE, GM
    GRONENBORN, AM
    APPELLA, E
    HARRINGTON, RE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) : 8591 - 8595
  • [4] Crystal Structure of the p53 Core Domain Bound to a Full Consensus Site as a Self-Assembled Tetramer
    Chen, Yongheng
    Dey, Raja
    Chen, Lin
    [J]. STRUCTURE, 2010, 18 (02) : 246 - 256
  • [5] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [6] GOF Mutant p53 in Cancers: A Therapeutic Challenge
    Dolma, Lobsang
    Muller, Patricia A. J.
    [J]. CANCERS, 2022, 14 (20)
  • [7] Mutant p53: one name, many proteins
    Freed-Pastor, William A.
    Prives, Carol
    [J]. GENES & DEVELOPMENT, 2012, 26 (12) : 1268 - 1286
  • [8] A TRANSCRIPTIONALLY ACTIVE DNA-BINDING SITE FOR HUMAN P53 PROTEIN COMPLEXES
    FUNK, WD
    PAK, DT
    KARAS, RH
    WRIGHT, WE
    SHAY, JW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) : 2866 - 2871
  • [9] Structural and Drug Targeting Insights on Mutant p53
    Gomes, Ana Sara
    Ramos, Helena
    Inga, Alberto
    Sousa, Emilia
    Saraiva, Lucilia
    [J]. CANCERS, 2021, 13 (13)
  • [10] Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2
    Gorina, S
    Pavletich, NP
    [J]. SCIENCE, 1996, 274 (5289) : 1001 - 1005